The Myopia Podcast
#79: What do we know about Atropine! with Mark Bullimore and Patrick Johnson from Sydnexis
I want to give a special thank you to Syndexis for being a sponsor of The Myopia Podcast. If you're not aware Syndexis is a biopharmaceutical company that was founded in 2014, they're based in Del Mar California.
Their mission is to develop a proprietary stable accurate effective
safe topical eye drop to treat the progression of myopia in children
and to minimize the risk of co-morbidities later in life. They're on the cusp of a new treatment paradigm to fight myopia progression in children, they're in the late stage of their pivotal phase 3 trial for their investigation medication SYD1 01.
The Myopia Podcast and myself are rooting for them and are watching Syndexis closely.
Stay tuned!
I want to give a special thank you to Syndexis for being a sponsor of The Myopia Podcast. If you're not aware Syndexis is a biopharmaceutical company that was founded in 2014, they're based in Del Mar California.
Their mission is to develop a proprietary stable accurate effective
safe topical eye drop to treat the progression of myopia in children
and to minimize the risk of co-morbidities later in life. They're on the cusp of a new treatment paradigm to fight myopia progression in children, they're in the late stage of their pivotal phase 3 trial for their investigation medication SYD1 01.
The Myopia Podcast and myself are rooting for them and are watching Syndexis closely.
Stay tuned!